Mounjaro
Generic name: tirzepatide (mown-JAHR-OH) [ mown-JAHR-OH ]
Dosage form: injection, for subcutaneous use
What is Mounjaro?
- Mounjaro is an injectable prescription medicine that is used to treat adults with type 2 diabetes mellitus.
- Mounjaro is a type of medicine called a GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. GIP has been shown to decrease food intake and increase energy expenditure which results in weight loss. When combined with a GLP-1 receptor agonist, it may result in greater positive effects on blood glucose and body weight.
- It is not known if this medicine can be used in people who have had pancreatitis.
- Mounjaro is not for use in people with type 1 diabetes.
- It is not known if this medicine is safe and effective for use in children under 18 years of age.
What is Mounjaro used for?
- Mounjaro is used along with diet and exercise to improve improve blood sugar (glucose) in adults with type 2 diabetes.
- Type 2 diabetes is a chronic disease characterized by high levels of sugar in the blood.
Important information
Mounjaro may cause serious side effects, including:
- Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Mounjaro and medicines that work like Mounjaro caused thyroid tumors, including thyroid cancer. It is not known if Mounjaro will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
- Do not use this medicine if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC), or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Who should not use Mounjaro?
Do not use this medicine if:
- you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- you have had a serious allergic reaction to tirzepatide or any of the ingredients. See the end of this page for a complete list of ingredients.
Before using Mounjaro
Before you start treatment, tell your healthcare provider about all of your medical conditions, including if you:
- have or have had problems with your pancreas or kidneys.
- have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food.
- have a history of diabetic retinopathy.
- are pregnant or plan to become pregnant. It is not known if Mounjaro will harm your unborn baby. Tell your healthcare provider if you become pregnant during treatment.
- Birth control pills by mouth may not work as well while using M..
